King's College London, Institute of Psychiatry, London, UK.
OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK.
World Psychiatry. 2015 Oct;14(3):322-32. doi: 10.1002/wps.20250.
An accurate detection of individuals at clinical high risk (CHR) for psychosis is a prerequisite for effective preventive interventions. Several psychometric interviews are available, but their prognostic accuracy is unknown. We conducted a prognostic accuracy meta-analysis of psychometric interviews used to examine referrals to high risk services. The index test was an established CHR psychometric instrument used to identify subjects with and without CHR (CHR+ and CHR-). The reference index was psychosis onset over time in both CHR+ and CHR- subjects. Data were analyzed with MIDAS (STATA13). Area under the curve (AUC), summary receiver operating characteristic curves, quality assessment, likelihood ratios, Fagan's nomogram and probability modified plots were computed. Eleven independent studies were included, with a total of 2,519 help-seeking, predominately adult subjects (CHR+: N=1,359; CHR-: N=1,160) referred to high risk services. The mean follow-up duration was 38 months. The AUC was excellent (0.90; 95% CI: 0.87-0.93), and comparable to other tests in preventive medicine, suggesting clinical utility in subjects referred to high risk services. Meta-regression analyses revealed an effect for exposure to antipsychotics and no effects for type of instrument, age, gender, follow-up time, sample size, quality assessment, proportion of CHR+ subjects in the total sample. Fagan's nomogram indicated a low positive predictive value (5.74%) in the general non-help-seeking population. Albeit the clear need to further improve prediction of psychosis, these findings support the use of psychometric prognostic interviews for CHR as clinical tools for an indicated prevention in subjects seeking help at high risk services worldwide.
准确识别处于精神病高危状态(CHR)的个体是进行有效预防干预的前提。有几种心理测量访谈可供使用,但它们的预后准确性尚不清楚。我们对用于检查高危服务转介的心理测量访谈进行了预后准确性荟萃分析。指标测试是一种已建立的 CHR 心理测量工具,用于识别有和没有 CHR(CHR+和 CHR-)的受试者。参考指标是 CHR+和 CHR-受试者随时间发生的精神病发作。数据使用 MIDAS(STATA13)进行分析。计算了曲线下面积(AUC)、汇总接收器工作特征曲线、质量评估、似然比、Fagan 列线图和概率修正图。纳入了 11 项独立研究,共有 2519 名寻求帮助的、主要是成年受试者(CHR+:N=1359;CHR-:N=1160)被转介到高危服务。平均随访时间为 38 个月。AUC 非常出色(0.90;95%CI:0.87-0.93),与预防医学中的其他测试相当,这表明在被转介到高危服务的受试者中具有临床实用性。荟萃回归分析显示,抗精神病药物暴露的效果,而仪器类型、年龄、性别、随访时间、样本量、质量评估、总样本中 CHR+受试者的比例均无影响。Fagan 列线图表明在一般非求助人群中阳性预测值较低(5.74%)。尽管明确需要进一步提高精神病预测的准确性,但这些发现支持将心理测量预后访谈用于 CHR,作为全球寻求高危服务帮助的受试者的有针对性预防的临床工具。